Login / Signup
Overcoming acquired resistance following osimertinib administration in EGFR-mutant lung adenocarcinoma.
Kyoichi Kaira
Hisao Imai
Hiroshi Kagamu
Published in:
Translational lung cancer research (2024)
Keyphrases
</>
small cell lung cancer
epidermal growth factor receptor
advanced non small cell lung cancer
tyrosine kinase
wild type